Smith & Nephew SNATS - 20 Year Stock Price History | SNN
Historical daily share price chart and data for Smith & Nephew SNATS since 1999 adjusted for splits. The latest closing stock price for Smith & Nephew SNATS as of April 24, 2019 is 38.29.
- The all-time high Smith & Nephew SNATS stock price is 40.46, which is 5.7% above the current share price.
- The Smith & Nephew SNATS 52-week high stock price is 40.46, which is 5.7% above the current share price.
- The Smith & Nephew SNATS 52-week low stock price is 32.40, which is 15.4% below the current share price.
- The average Smith & Nephew SNATS stock price for the last 52 weeks is 36.83.
| Smith & Nephew SNATS Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2019 | 38.6141 | 36.4000 | 40.4600 | 35.5100 | 38.2900 | 2.43% |
| 2018 | 36.0218 | 34.2179 | 39.1370 | 32.4000 | 37.3800 | 8.90% |
| 2017 | 33.1929 | 28.8624 | 37.7475 | 28.7758 | 34.3257 | 18.57% |
| 2016 | 30.8841 | 32.8692 | 33.4878 | 26.0907 | 28.9490 | -13.91% |
| 2015 | 32.7978 | 33.3647 | 35.4415 | 30.6779 | 33.6248 | -1.39% |
| 2014 | 30.2808 | 25.8154 | 35.8583 | 25.8154 | 34.0979 | 30.43% |
| 2013 | 21.6627 | 19.8568 | 26.1835 | 18.8484 | 26.1434 | 32.44% |
| 2012 | 17.8999 | 17.0745 | 19.8318 | 15.9151 | 19.7392 | 17.38% |
| 2011 | 17.7977 | 18.0890 | 20.6991 | 14.6251 | 16.8161 | -6.95% |
| 2010 | 16.3195 | 17.4964 | 18.2793 | 14.1065 | 18.0718 | 4.05% |
| 2009 | 13.3508 | 10.8519 | 17.4117 | 10.1761 | 17.3677 | 61.53% |
| 2008 | 17.9182 | 18.9682 | 22.5689 | 10.1162 | 10.7520 | -43.11% |
| 2007 | 19.7558 | 17.0814 | 22.3056 | 16.9835 | 18.8991 | 10.73% |
| 2006 | 14.4510 | 15.2752 | 17.1727 | 11.9982 | 17.0683 | 14.17% |
| 2005 | 15.3933 | 16.2227 | 16.8657 | 12.9852 | 14.9495 | -9.50% |
| 2004 | 15.6059 | 13.2311 | 18.4355 | 12.9022 | 16.5195 | 24.62% |
| 2003 | 10.4015 | 9.6648 | 13.3765 | 8.3743 | 13.2564 | 38.19% |
| 2002 | 9.0059 | 9.3110 | 9.9395 | 7.5273 | 9.5929 | 2.18% |
| 2001 | 7.6490 | 7.0033 | 9.4036 | 6.3715 | 9.3882 | 33.71% |
| 2000 | 5.9753 | 6.1129 | 7.0215 | 4.6477 | 7.0215 | 14.63% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $16.746B | $4.904B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $134.809B | 26.28 |
| Medtronic (MDT) | Ireland | $114.856B | 16.79 |
| Stryker (SYK) | United States | $69.039B | 24.64 |
| Boston Scientific (BSX) | United States | $49.279B | 23.63 |
| Baxter (BAX) | United States | $38.988B | 25.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.460B | 16.29 |
| Canopy Growth (CGC) | Canada | $16.646B | 0.00 |
| ResMed (RMD) | United States | $14.578B | 27.64 |
| Aurora Cannabis (ACB) | Canada | $9.230B | 65.07 |
| Bio-Rad Laboratories (BIO) | United States | $8.754B | 50.22 |
| Perrigo (PRGO) | Ireland | $6.685B | 10.84 |
| Hill-Rom Holdings (HRC) | United States | $6.417B | 19.85 |
| Insulet (PODD) | United States | $4.971B | 1666.40 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.857B | 0.00 |
| ICU Medical (ICUI) | United States | $4.694B | 29.07 |
| Haemonetics (HAE) | United States | $4.319B | 38.31 |
| Hutchison China MediTech (HCM) | China | $3.951B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.335B | 0.00 |
| NuVasive (NUVA) | United States | $3.048B | 26.48 |
| Neogen (NEOG) | United States | $3.014B | 49.01 |
| Quidel (QDEL) | United States | $2.477B | 22.16 |
| National Vision Holdings (EYE) | United States | $2.284B | 44.94 |
| Aphria (APHA) | $1.955B | 0.00 | |
| HEXO (HEXO) | $1.502B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $1.342B | 19.28 |
| VAREX IMAGING (VREX) | United States | $1.234B | 24.16 |
| Cardiovascular Systems (CSII) | United States | $1.222B | 877.50 |
| AtriCure (ATRC) | United States | $1.081B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.962B | 26.00 |
| Omeros (OMER) | United States | $0.930B | 0.00 |
| PetIQ (PETQ) | United States | $0.874B | 25.02 |
| Cerus (CERS) | United States | $0.826B | 0.00 |
| MacroGenics (MGNX) | United States | $0.805B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.759B | 0.00 |
| Evolus (EOLS) | United States | $0.721B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.720B | 24.51 |
| TG Therapeutics (TGTX) | United States | $0.706B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.596B | 25.95 |
| Surmodics (SRDX) | United States | $0.585B | 85.02 |
| LeMaitre Vascular (LMAT) | United States | $0.554B | 26.32 |
| Meridian Bioscience (VIVO) | United States | $0.551B | 16.42 |
| Quanterix (QTRX) | United States | $0.500B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.344B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.321B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.319B | 20.75 |
| BioLife Solutions (BLFS) | United States | $0.308B | 127.08 |
| Vapotherm (VAPO) | United States | $0.283B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.263B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.223B | 0.00 |
| Owens & Minor (OMI) | United States | $0.214B | 2.93 |
| Zynex (ZYXI) | United States | $0.175B | 18.69 |
| Bovie Medical (APYX) | United States | $0.149B | 0.00 |
| Chimerix (CMRX) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.128B | 6.85 |
| Chembio Diagnostics (CEMI) | United States | $0.123B | 0.00 |
| Surface Oncology (SURF) | United States | $0.112B | 0.00 |
| United-Guardian (UG) | United States | $0.088B | 20.27 |
| Female Health (VERU) | United States | $0.086B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.083B | 0.00 |
| Neurotrope (NTRP) | United States | $0.076B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.067B | 19.86 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.066B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.049B | 0.00 |
| ImmuCell (ICCC) | United States | $0.044B | 0.00 |
| Senestech (SNES) | United States | $0.035B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.030B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.025B | 0.00 |
| Myomo (MYO) | United States | $0.021B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.017B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 12.64 |
